Mizuho Securities analyst Uy Ear maintains $Alkermes (ALKS.US)$ with a buy rating, and sets the target price at $40.
According to TipRanks data, the analyst has a success rate of 41.9% and a total average return of 3.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Alkermes (ALKS.US)$'s main analysts recently are as follows:
The adjustment in valuation multiple for Alkermes, influenced by the recent trend among biotech peers, is the basis for the revised outlook. The upcoming expert discussion on sleep disorders, particularly anticipating orexin data in 2025, will concentrate on the projected updates from Alkermes and Centessa's Phase 2 narcolepsy data.
The firm adjusted its forecast following a sum-of-the-parts analysis. The discussion among investors is increasingly focusing on ALKS 2680, anticipating more spotlight as it heads towards Phase 2 outcomes in the latter half of 2025. Its potential impact on the $10B branded narcolepsy and idiopathic hypersomnia markets is being closely watched.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
